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Abstract (250) 44 
The enteric nervous system (ENS) provides the intrinsic neural control of the 45 
gastrointestinal tract (GIT) and regulates virtually all GI functions. Altered neuronal 46 
activity within the ENS underlies various GI disorders with stress being a key 47 
contributing factor. Thus, elucidating the expression and function of the 48 
neurotransmitter systems which determine neuronal excitability within the ENS, such 49 
as the GABA-GABAA receptor (GABAAR) system, could reveal novel therapeutic 50 
targets for such GI disorders. Molecular and functionally diverse GABAARs modulate 51 
rapid GABAergic-mediated regulation of neuronal excitability throughout the nervous 52 
system. However, the cellular and sub-cellular GABAAR subunit expression patterns 53 
within neurochemically-defined cellular circuits of the mouse ENS, together with the 54 
functional contribution of GABAAR subtypes to GI contractility remains to be 55 
determined. Immunohistochemical analyses revealed that immunoreactivity for the 56 
GABAAR gamma (γ) 2 and alphas (α) 1, 2, 3 subunits was located on somato-57 
dendritic surfaces of neurochemically distinct myenteric plexus neurons, whilst being 58 
on axonal compartments of submucosal plexus neurons. In contrast, 59 
immunoreactivity for the α4-5 subunits was only detected in myenteric plexus 60 
neurons. Furthermore, α-γ2 subunit immunoreactivity was located on non-neuronal 61 
interstitial cells of Cajal. In organ bath studies, GABAAR subtype specific ligands had 62 
contrasting effects on the force and frequency of spontaneous colonic longitudinal 63 
smooth muscle contractions. Finally, enhancement of γ2-GABAAR function with 64 
alprazolam reversed the stress-induced increase in the force of spontaneous colonic 65 
contractions. The study demonstrates the molecular and functional diversity of the 66 
GABAAR system within the mouse colon providing a framework for developing 67 
GABAAR-based therapeutics in GI disorders. 68 
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Introduction 69 
 70 
The ENS is a large collection of neurons within the muscle wall of the gastrointestinal 71 
tract (GIT) which provides the intrinsic neural control of virtually all GI functions 72 
(Goyal and Hirano, 1996; Furness, 2006) with ENS neuropathies being thought to 73 
underlie a range of GI disorders (Di Nardo et al., 2008; Furness, 2008). Furthermore, 74 
exposure to psychosocial stress adversely affects GI function and is a risk factor for 75 
the development of GI disorders such as inflammatory bowel disease (IBD) and 76 
irritable bowel syndrome (IBS) (Mawdsley and Rampton, 2005; Larauche et al., 77 
2009; Konturek et al., 2011). Importantly, altered levels of neuronal activity within the 78 
ENS are implicated in such GI disorders (Margolis and Gershon, 2009; Ohman and 79 
Simren, 2010) with treatment aimed primarily at the alleviation of the symptoms (Di 80 
Nardo et al., 2008). Thus, elucidating the expression and function of the 81 
neurotransmitter systems which determine neuronal excitability within the ENS, such 82 
as the GABA-GABAAR system (Krantis, 2000) could reveal novel therapeutic targets 83 
for such GI disorders.  84 
 85 
GABAARs are chloride permeable integral membrane ion channels composed of five 86 
interacting subunit proteins which mediate the effects of the neurotransmitter GABA 87 
(Farrant and Nusser, 2005). While only five subunits are required to form a functional 88 
receptor, up to nineteen molecularly distinct GABAAR subunits have been identified 89 
(Olsen and Sieghart, 2009). GABAAR biology has been pioneered in the central 90 
nervous system (CNS) where diverse GABAAR subunit assembly combinations 91 
manifest in functionally (Belelli et al., 2009; Eyre et al., 2012) and pharmacologically 92 
(Rudolph and Knoflach, 2011) diverse receptor subtypes within distinct regions 93 
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(Wisden et al., 1992; Fritschy and Mohler, 1995; Hortnagl et al., 2013) of the CNS, 94 
emphasising the importance of identifying which particular GABAAR subunits are 95 
expressed within a particular neural system. Despite the recognised importance of 96 
GABAARs to neural function and clinical medicine, relatively less is known about 97 
GABAAR expression and function within the peripheral nervous system and the ENS 98 
in particular.  99 
 100 
GABAAR subunit mRNA expression has been demonstrated in the rat small intestine 101 
(Zeiter et al., 1996; Poulter et al., 1999). However, the expression of particular 102 
GABAAR subtypes at the cellular and sub-cellular level of neurochemically-defined 103 
cells remains to be fully elucidated (Krantis et al., 1995). Furthermore, while pan-104 
GABAAR ligands have been used to demonstrate the effects of GABAAR modulation 105 
on intestinal contractility (Tonini et al., 1987; Tonini et al., 1989a; Roberts et al., 106 
1993; Hebeiss and Kilbinger, 1999; Bayer et al., 2002; Bayer et al., 2003), the 107 
functional contribution of specific GABAAR subtypes to GI contractility is yet to be 108 
determined. Here, we provide high resolution immuno-localisation of the GABAAR 109 
α1-5 and γ2 subunits on neurochemically-defined ENS cells of the mouse colon and 110 
use GABAAR subunit-selective drugs to demonstrate that the pharmacological 111 
enhancement of the function of different GABAAR subtypes has contrasting effects 112 
on the amplitude and frequency of spontaneous colonic longitudinal smooth muscle 113 
contractions in vitro. Finally GABAAR ligands reversed the stress-induced changes in 114 
colonic contractility suggesting a role for these agents in treating stress-induced GI 115 
disorders.   116 
 117 
 118 
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Materials and Methods 119 
 120 
All procedures involving experimental animals were approved by the Ethics 121 
Committee of the University of Portsmouth and were performed by a personal 122 
licence holder, in accordance with the Animals (Scientific Procedures) Act, 1986 123 
(UK) and associated procedures. 124 
 125 
Reverse transcription-polymerase chain reaction (RT-PCR) 126 
RT-PCR was used to detect which GABAAR subunits are expressed in the mouse 127 
colon at the mRNA level with matched brain tissue used as the positive control. Adult 128 
male C57/BL6J mice (Charles River) (N=3) were killed by cervical dislocation and 129 
the segments of the colon and whole brain removed and snap frozen in liquid 130 
nitrogen. The frozen tissue was homogenised from which RNA was extracted using 131 
an RNeasyR mini kit (Qiagen) according to the manufacturer’s protocol. RNA was 132 
reverse transcribed into complementary DNA (cDNA) using SuperScript™ First-133 
Strand Synthesis System for RT-PCR kit (Invitrogen). Equal amounts of cDNA (1-2 134 
µl) were then used for subsequent polymerase chain reaction (PCR) using GoTaqR 135 
green mastermix (Promega), PCR grade water and specific primers. Exon-exon 136 
spanning GABAAR subunit specific PCR primers used in the study (Table 1) have 137 
previously been published (Glassmeier G et al., 1998; Gustincich S et al., 1999; Tan 138 
S et al., 2011). The RT-PCR transcript products for the GABAAR subunits and the 139 
positive control β-actin from brain and colon tissue were run on a 2% agarose gel 140 
and the DNA was visualised under ultraviolet light using a SYBR green-based DNA 141 
stain. 142 
 143 
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Tissue preparation for immunohistochemistry 144 
Adult male C57/BL6J (Charles River) mice were anaesthetised with isoflurane and 145 
pentobarbitone (1.25 mg/kg of bodyweight; i.p.). The animals were transcardially 146 
perfused using a fixative containing 1% paraformaldehyde and 15% v/v saturated 147 
picric acid in 0.1M phosphate buffer (pH 7.4) according to previously described 148 
protocols (Corteen et al., 2011). After perfusion, the brains and colons were removed 149 
and post-fixed in the same fixative over night at 4oC. The next day, tissue was 150 
washed in 0.1M phosphate buffer until it was clear of the fixative. Whole-mount 151 
preparations of the longitudinal muscle-myenteric plexus and circular muscle-152 
submucosal plexus were obtained using a dissecting microscope and fine forceps, 153 
which were then stored in 0.1M phosphate buffer containing 0.05% sodium azide.  154 
 155 
Immunohistochemistry 156 
The native GABAAR subunit immunoreactivity patterns within the ENS of the mouse 157 
colon were confirmed in at least 4 animals. Non-specific binding of secondary 158 
antibodies was blocked by incubating the tissue with 20% normal horse serum for 2 159 
hours at room temperature. The tissue was incubated with cocktails of primary 160 
antibodies (Table 2), diluted in Tris buffer saline containing 0.3% Triton X-100 (TBS-161 
Tx) and 20% normal horse serum, overnight at 4°C. After washing with TBS-Tx, the 162 
tissue was incubated in a mixture of appropriate secondary antibodies conjugated 163 
with either Alexa Fluor 488 (Invitrogen, Eugene, OR), indocarbocyanine (Cy3; 164 
Jackson ImmunoResearch), and indodicarbocyanine (Cy5; Jackson 165 
ImmunoResearch) for 2 hours at room temperature. The tissue was washed in TBS-166 
Tx and mounted on glass slides in Mowiol mounting medium (Polysciences) and 167 
then cover slipped.  168 
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Antibody specificity 169 
Although the specificity of all the antisera against the GABAAR subunits used in this 170 
study have been reported upon extensively in other studies concerning the CNS (see 171 
Table 2), the specificity of the signal obtained in the ENS in this study was confirmed 172 
using perfusion-fixed, matched brain-colon tissue from GABAAR subunit-specific 173 
gene deleted mice. Method specificity was also tested by omitting the primary 174 
antibodies in the incubation sequence. To confirm the absence of cross reactivity 175 
between IgGs in double and triple immunolabelling experiments, some sections were 176 
processed through the same immunohistochemical sequence, except that only an 177 
individual primary antibody was applied with the full complement of secondary 178 
antibodies.  179 
 180 
Image acquisition 181 
Sections were examined with a confocal laser-scanning microscope (LSM710; Zeiss, 182 
Oberkochen, Germany) using either a Plan Apochromatic 40x DIC oil objective 183 
(NA1.3) (pixel size 0.29 μm), a Plan Apochromatic 63x DIC oil objective (NA1.4) 184 
(pixel size 0.13 μm) or a Plan Apochromatic 100x DIC oil objective (NA1.46) (pixel 185 
size 0.08 μm). Z-stacks were used for routine evaluation of the labelling. All images 186 
presented represent a single optical section. These images were acquired using 187 
sequential acquisition of the different channels to avoid cross-talk between 188 
fluorophores, with the pinholes adjusted to one airy unit. Images were processed 189 
with the software Zen2008 Light Edition (Zeiss, Oberkochen, Germany) and 190 
exported into Adobe Photoshop. Only brightness and contrast were adjusted for the 191 
whole frame, and no part of a frame was enhanced or modified in any way.  192 
 193 
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Isometric tension recordings of the effects of GABAAR subunit-specific ligands on 194 
colonic longitudinal muscle contractions from isolated mouse colon segments 195 
The pharmacological activation of GABAARs within the colon was explored with a 196 
view to understanding their potential roles in one aspect of colon physiology, namely 197 
colonic smooth muscle contractility. Intestinal motility or peristalsis arises from the 198 
coordinated contraction and relaxation of circular and longitudinal smooth muscles 199 
(Smith and Robertson, 1998). The effect of the GABA-GABAAR system on the 200 
contractility of intestinal circular smooth muscles has been widely explored (Tonini et 201 
al., 1989b; Tonini et al., 1989a; Bayer et al., 2002; Bayer et al., 2003). Therefore, we 202 
focused on the effect of ENS GABAAR activation on longitudinal smooth muscle 203 
contraction by measuring the changes in the force and frequency of spontaneous 204 
contractions in vitro. The activity of the interstitial cells of Cajal (ICC) is thought to 205 
underlie such intestinal spontaneous contractions (Sanders and Ward, 2006). Six to 206 
eight week old male mice were killed by cervical dislocation and the distal colon was 207 
removed and immediately placed in physiological solution containing (mM): NaCl 208 
140, NaHCO3 11.9, D+ glucose 5.6, KCl 2.7, MgCl2.6H2O 1.05, NaH2PO4.2H2O 0.5, 209 
CaCl2 1.8, warmed to 32°C. The intraluminal contents were removed by gently 210 
flushing the colon with the physiological solution. Approximately 2 cm-long segments 211 
were mounted in a Harvard organ bath (10 ml chamber) filled with the physiological 212 
solution (32oC) and bubbled with gas containing 95% O2 and 5% CO2. Contractile 213 
activity for each colon tissue strip was recorded using an isometric force transducer 214 
(range 0-25 g) connected to a bridge amplifier, which was in turn connected to a 215 
dedicated data acquisition system (Power Lab 2.20 AD Instruments). The sampling 216 
frequency was set to 40 Hz and the sensitivity of recording was set to 500 mV. The 217 
apparatus was then calibrated using a one gram weight in order to express the 218 
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changes in the amplitude detected by the transducer into grams of force. The tissue 219 
was then placed under 1 gram of resting tension and allowed to equilibrate for 30 220 
minutes. The AD instrument lab chart 7 program installed on a PC was used to 221 
monitor record and analyse the activity. After a stable baseline was established, the 222 
drugs were added to the bath and the tissue was allowed to reach maximum 223 
response. Ten minute epochs before and after the drug additions were used for 224 
quantification of the drug-induced changes in the force and frequency of colonic 225 
spontaneous contractions. One piece of tissue was used per animal. The frequency 226 
and amplitude of individual spontaneous contractions was manually counted before 227 
and after the drug and the average for that animal determined. A mean value for the 228 
individual averages was obtained for a particular drug. An N value thus represents 229 
one animal and the data are presented as the mean ± SD.  230 
In a subset of experiments, we investigated the effects of alprazolam on the 231 
contractile responses evoked by transmural nerve stimulation (10 Hz, 60 V and 0.2 232 
ms duration) (Bayer et al., 2003). The electric pulses were delivered for 10 seconds 233 
and a single contraction was observed as a result. The tissue was then washed 234 
several times with the physiological solution and allowed to stabilise for 15 minutes. 235 
Alprazolam or TTX were then individually added to the bath for 10 minutes after 236 
which the electrical stimulation was repeated.   237 
 238 
Acute restraint stress 239 
To probe the possible involvement of GABAARs in stress-induced alterations of GI 240 
contractile function or provide evidence of their therapeutic potential in associated 241 
disorders, we exposed mice to acute restraint stress (Buynitsky and Mostofsky, 242 
2009) and compared the effects of the benzodiazepine alprazolam on the force and 243 
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frequency of spontaneous colonic contractions. This model was used since it 244 
induces a robust local stress response within the GIT which engages a range of 245 
intestinal cellular elements such as neurons, muscle and immune cells (Tache and 246 
Perdue, 2004; Zheng et al., 2009).  We focused on only one aspect of such a stress-247 
response, the changes in longitudinal smooth muscle contractility.  Animals were 248 
divided into stress and control experimental groups one week prior to the start of the 249 
experiment in order to allow adaptation to the new cage environment before 250 
commencing the stress. To deliver restraint, mice were restrained for 60 minutes 251 
using a Broome rodent restrainer (Harvard Apparatus # 52-0470). During the period 252 
of restraint, the mice were kept individually in standard housing cages containing a 253 
thin layer of corn cob. Control mice remained in their original cages and were left 254 
undisturbed in their home environment. Immediately after the period of restraint, the 255 
animals were killed by cervical dislocation and used for isometric tension recordings. 256 
 257 
Drugs  258 
The following drugs were used in this study: zolpidem (Tocris Biosciences), 259 
alprazolam (Sigma Aldrich), TP003 (Tocris Biosciences), THIP hydrochloride (Tocris 260 
Biosciences), L-655, 708 (Tocris Biosciences). Apart from THIP hydrochloride which 261 
was dissolved in distilled water, all other drugs were dissolved in DMSO. DMSO at 262 
the bath concentrations used had no effect on the amplitude or frequency of colonic 263 
spontaneous contractions in agreement with previous evidence (Bayer et al., 2002).                                     264 
 265 
 266 
 267 
 268 
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Statistical analysis 269 
All data are presented as the arithmetic mean ± SEM unless stated otherwise. 270 
Statistical comparisons were made using either Student’s t test (paired or unpaired 271 
where appropriate) or repeated-measures ANOVA (one-way), followed by the 272 
Tukey’s post hoc test.   273 
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Results 274 
 275 
GABAAR subunit mRNA expression in the mouse colon  276 
Currently, up to 19 different GABAAR subunits are known to be expressed within the 277 
CNS (Sieghart, 2006). Previous studies on GABAAR subunit expression in the PNS 278 
did not specifically report expression patterns within the mouse colon (Akinci and 279 
Schofield, 1999; Poulter et al., 1999). RT-PCR performed on homogenates of mouse 280 
colon revealed mRNA expression for 14 out of the 16 GABAAR subunits investigated 281 
(Fig. 1) (N= 3 animals). No corresponding signal of the same size was detected for 282 
the GABAAR alpha6 and epsilon subunits in the colon with mouse whole brain 283 
homogenates serving as a positive control (Fig. 1).  284 
 285 
Immunolocalisation of GABAergic synaptic marker proteins in the ENS of the mouse 286 
colon 287 
Immunoreactivity for putative pre- and postsynaptic GABAergic marker proteins was 288 
used to determine the distribution of GABAergic innervation across neuronal and 289 
non-neuronal cell-types in whole mount preparations of the mouse colon. 290 
Microtubule associated protein 2 (MAP2), a pan-neuronal marker protein was used 291 
to visualise the somato-dendritic domains of neurons located within the myenteric 292 
and submucosal plexuses. Immunoreactivity for the vesicular GABA transporter 293 
(VGAT), a protein which within the CNS is selectively expressed in GABAergic axon 294 
terminals was used to locate presumptive GABAergic input to different sub-cellular 295 
domains while immunoreactivity for neuroligin2 (NL2), a protein which in the CNS is 296 
selectively localised to GABAergic and glycinergic inhibitory synapses (Varoqueaux 297 
et al., 2004) was used to locate putative inhibitory postsynaptic domains with the 298 
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caveat that ultrastructural studies are required to unequivocally demonstrate that, as 299 
is the case in the CNS, VGAT and NL2 are located at inhibitory pre- and 300 
postsynaptic junctions. Immunoreactivity for the tyrosine-protein kinase Kit, c-Kit, 301 
was used to detect the non-neuronal interstitial cells of Cajal (ICC) (Maeda et al., 302 
1992) which provide pace-maker activity in terms of colonic contractility (Garcia-303 
Lopez et al., 2009). Immunoreactivity for VGAT was widely distributed amongst 304 
MAP2 immunoreactive somata and dendrites as well as c-Kit immunoreactive 305 
profiles located within myenteric and submucosal plexuses (Fig. 2A). 306 
Immunoreactivity for NL2 presented as individual clusters which were concentrated 307 
on somatic and dendritic compartments of myenteric and submucosal plexus 308 
neurons and were closely apposed to VGAT immunoreactive puncta (Fig. 2B). VGAT 309 
immunoreactive clusters were also evident within colonic muscle layers and were 310 
distinctly associated with nitric oxide synthase (NOS) immunoreactive axon terminals 311 
which appeared to innervate c-Kit immunoreactive ICC (Fig. 2C). Thus, the putative 312 
sites of GABA release and predictive location of GABAergic receptors within the 313 
ENS of the mouse colon includes the neurons of the myenteric and submucosal 314 
plexuses as well as the non-neuronal ICCs.  315 
 316 
Guided by the patterns of GABAergic innervation and the GABAAR subunit mRNA 317 
expression patterns, immunohistochemistry and confocal microscopy was used to 318 
localise the expression of the GABAAR gamma2 (γ2) and alphas1-5 (α 1-5) subunits 319 
within neurochemically defined cell-types of the ENS of the mouse colon. GABAAR-320 
subunit preferring ligands were then used to investigate the consequences of 321 
GABAAR activation on spontaneous colonic longitudinal muscle contractions in vitro.   322 
 323 
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Expression of the γ2 subunit in the mouse colon and its role in the regulation of 324 
longitudinal smooth muscle spontaneous contractions 325 
Immunoreactivity for the γ2 subunit was widely distributed across both neuronal and 326 
non-neuronal cell-types of myenteric (Fig. 3A), and submucosal (Fig. 3B) plexuses 327 
as well as the intramuscular layer (Fig. 3C). Within the myenteric plexus, 328 
immunoreactivity for the γ2 subunit presented as distinct clusters almost exclusively 329 
located on the somatic and dendritic plasma membranes of nitric oxide synthase 330 
(NOS)-, serotonin (5HT)-, corticotrophin releasing hormone (CRH)-, somatostatin 331 
(SOM) and choline acetyl transferase (Chat)-immunoreactive neurons (Fig. 3A). In 332 
contrast to the membrane-bound location of γ2 subunit immunoreactivity in 333 
myenteric neurons, the location of the signal in NOS-immunopositive submucosal 334 
plexus neurons was predominantly cytoplasmic which might be suggestive of a 335 
presynaptic locus of expression (Fig. 3B). Thus, the targeting of γ2 subunit–336 
containing GABAARs (γ2-GABAARs) to specific sub-cellular domains of ENS neurons 337 
is cell-type specific. Apart from expression in neurons, γ2 subunit immunoreactivity 338 
was also evident on putative ICC immunopositive for c-Kit located in proximity to the 339 
submucosal plexus (Fig. 3B) and muscle layers (Fig. 3C).  340 
 341 
ICC are hypothesised to be the cellular links between ENS neurons and intestinal 342 
smooth muscle (Sanders and Ward, 2006; Huizinga et al., 2009) and are thus 343 
predominantly involved in GI contractility. Intestinal smooth muscle cells possess 344 
spontaneous rhythmic oscillations in their membrane potential, or slow waves which 345 
are the source of spontaneous contractions (Iino and Horiguchi, 2006). Myenteric 346 
and submucosal ICC are reportedly involved in the generation and propagation of 347 
these slow waves (Hirst and Ward, 2003; Sanders et al., 2004). In addition, the 348 
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intramuscular ICC which are distributed amongst smooth muscle cells act as 349 
mediators of neurotransmission from the ENS to intestinal muscle cells (Ward et al., 350 
2004). Importantly, it has been demonstrated that GABA and the GABAAR agonist 351 
muscimol can modulate the amplitude of these spontaneous contractions in the rat 352 
colon (Bayer et al., 2002). The location of γ2 subunit immunoreactivity at the 353 
interface between cell-types which are implicated in regulating colon contractility 354 
suggests a possible involvement of γ2 subunit containing GABAARs (γ2-GABAARs) 355 
in such functions. Since the effects of GABAAR ligands on the activity of GI circular 356 
smooth muscles have been reported on extensively (Tonini et al., 1989b; Tonini et 357 
al., 1989a; Bayer et al., 2002; Bayer et al., 2003), we focussed exclusively on their 358 
effects on longitudinal smooth muscle contractility. We therefore applied the 359 
benzodiazepine alprazolam to whole segments of mouse colon in a conformation 360 
that detects predominantly longitudinal smooth muscle activity and determined the 361 
changes in the force and frequency of spontaneous contractions; thus our future 362 
reference in the manuscript to colonic contractility refers to longitudinal smooth 363 
muscle activity.  Benzodiazepines as a class act as positive allosteric modulators at 364 
α1/2/3/5-β-γ2-GABAARs and therefore enhance the endogenous effects of GABA 365 
(Rudolph and Knoflach, 2011) with alprazolam in particular being a high potency 366 
benzodiazepine widely prescribed for the treatment of generalized anxiety, panic 367 
attacks and depression. Alprazolam at a bath concentration of 10 µM induced a 368 
significant decrease in the basal tone of the tissue (from - 0.42 ± 0.09 grams to, - 369 
0.52 ± 0.1 grams, N = 4 animals; P = 0.003, paired Student’s t test). Alprazolam also 370 
significantly decreased the force of spontaneous contractions (from 0.19 ± 0.06 371 
grams to 0.08 ± 0.04 grams, N = 4 animals; P = 0.007, paired Student’s t test) and 372 
increased their frequency (from 0.054 ± 0.003 Hz to 0.071 ± 0.009 Hz, P = 0.0244, 373 
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paired Student’s t test). Thus, the activation of γ2-GABAARs (i.e., GABAARs 374 
containing - amongst others - the γ2 subunit) has a direct effect on the amplitude and 375 
frequency of spontaneous colonic longitudinal muscle contractions as well as the 376 
basal tone of the colon. 377 
 378 
The intricate expression patterns of the γ2 subunit within the neurochemically 379 
diverse cell networks of the ENS raises the question whether the effects of 380 
alprazolam on colonic contractility occur directly or via secondary mediators. Two 381 
key neurochemical mediators of colonic contractility are acetylcholine which, within 382 
the intestine, signals primarily via cholinergic muscarinic receptors to cause intestinal 383 
contraction (Furness, 2006) and nitric oxide (NO) which acts via various intra- and 384 
inter-cellular pathways to cause intestinal relaxation (Shah et al., 2004). To explore 385 
this further, we investigated the effects of alprazolam on the basal tone of the colon 386 
as well as the force and frequency of spontaneous colonic contractions in the 387 
presence of either atropine a cholinergic muscarinic receptor antagonist or L-NAME, 388 
an inhibitor of the NO synthesising enzyme nitric oxide synthase. Alprazolam 389 
significantly [F (4, 12) 16.93, P < 0.0001; Repeated measures ANOVA, RMA] reduced 390 
the basal tone of the colon both alone (P < 0.05, RMA) as well as in the presence of 391 
atropine (P < 0.05, RMA; N = 5 animals) (Fig. 3 D1). Furthermore, alprazolam 392 
significantly [F (4, 12) 52, P < 0.0001; RMA] decreased the force of spontaneous 393 
colonic contractions on its own (P < 0.05, RMA) as well as in the presence of 394 
atropine (P < 0.05, RMA; N = 5 animals) (Fig. 3 D1, 2). In contrast, while alprazolam 395 
significantly [F (4, 12) 4.22, P = 0.02; RMA] increased the frequency of colonic 396 
contractions on its own (P < 0.05, RMA), this effect was blocked in the presence of 397 
atropine (P > 0.05, RMA; N = 5 animals) (Fig. 3 D3).  Thus, the muscarinic 398 
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cholinergic system is required for the effect of alprazolam on the frequency but not 399 
the force of colonic contractions.   400 
 401 
Whilst alprazolam significantly [F (6, 18) 11, P = 0.0064; RMA] reduced the basal tone 402 
of the colon on its own (P < 0.05, RMA; N = 7 animals), this effect was abolished in 403 
the presence of L-NAME (P > 0.05, RMA). In contrast to atropine, the alprazolam-404 
induced [F (6, 18) 5.78, P = 0.0017; RMA] decrease in the force of colonic contraction 405 
(P < 0.05, RMA) was blocked in the presence of L-NAME (P > 0.05, RMA; N = 7 406 
animals) (Fig. 3 E1, 2). However, the significant [F (6, 18) 6.45, P = 0.0001; RMA] 407 
alprazolam-induced increase in the frequency of colonic contraction (P < 0.05, RMA) 408 
still persisted in the presence of L-NAME (P < 0.05, RMA; N = 7 animals) (Fig. 3 E3). 409 
Thus, the nitric oxide system is engaged in mediating the effects of alprazolam on 410 
the basal tone as well as the force of colonic contractions.  411 
 412 
Whilst the direct readout of the preparation used is smooth muscle contraction, it 413 
would be informative to confirm the involvement of the ENS in such effects. We 414 
therefore directly engaged neural elements by transmurally stimulating the colon 415 
segments using electrical field stimulation and measured the evoked contractile 416 
response (Fig. 4A). The application of tetrodotoxin (TTX), a blocker of voltage-gated 417 
sodium channels, which in this preparation, are  expressed by neuronal elements,  418 
significantly reduced the amplitude of the evoked response (P = 0.003, paired 419 
Student’s t test) (Fig. 4B) confirming that neural activity underlies the evoked 420 
response. The application of alprazolam mimicked the effect of TTX by significantly 421 
reducing the amplitude of the evoked response (P = 0.01, paired Student’s t test) 422 
(Fig. 4B). There was no significant difference between the evoked responses 423 
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produced by TTX and alprazolam (P = 0.07, unpaired Student’s t test). This suggests 424 
that alprazolam directly engages the ENS and dampens overall neuronal excitability. 425 
Dedicated microelectrode studies are required to dissect the effects of GABAAR 426 
subtype function at the single cell or cellular network which manifest in regulating 427 
ENS out as a whole.   428 
 429 
Confirmation of the specificity of GABAAR subunit immunoreactivity in brain and 430 
colon tissue from GABAAR α subunit specific gene-deleted (α
-/-) and WT mice 431 
 432 
The specificity of the immunoreactivity patterns obtained by the antibodies against 433 
the α1-5 subunits was confirmed in tissue from the brain (Fig. 5) and colon (Fig. 6) of 434 
WT and α1-5-/- mice.  435 
 436 
Expression of the α1 subunit in the mouse colon and its role in the regulation of 437 
longitudinal smooth muscle spontaneous contractions 438 
Immunoreactivity for the α1 subunit was located on neurons of both the myenteric 439 
and submucosal plexuses (Fig. 7A, B). Clustered immunoreactivity for the α1 subunit 440 
was evident on MAP2 immunopositive myenteric plexus neurons closely mirroring 441 
the expression pattern of the γ2 subunit signal (Fig. 7A1). Immunoreactivity for the 442 
α1 subunit presented as distinct clusters associated with VGAT immunoreactive 443 
clusters in close proximity to somato-dendritic plasma membranes, which were 444 
delineated by the voltage-gated potassium channel 2.1 (Kv2.1), thus implying 445 
expression at inhibitory synaptic junctions (Fig. 7A2). In addition, this clustered 446 
somato-dendritic pattern of α1 subunit immunoreactivity was also evident on NOS, 447 
Chat-, 5HT-, and CRH-immunopositive myenteric neurons (Fig. 7A3-6). Furthermore, 448 
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α1 subunit immunoreactivity was clustered on Chat-immunopositive varicosities in 449 
the muscle layer (Fig. 7A7). Immunoreactivity for the α1 subunit within submucosal 450 
plexus neurons also closely mirrored the pattern of the γ2 subunit, appearing wholly 451 
cytoplasmic in NOS-immunoreactive neurons, with distinct α1 subunit 452 
immunoreactive clusters evident on NOS-immunoreactive axonal varicosities (Fig. 453 
7B). This immunolocalisation pattern suggests that α1-GABAARs are located 454 
postsynaptically on myenteric plexus neurons and presynaptically on submucosal 455 
plexus neurons.  456 
 457 
In order to investigate whether the activation of α1-GABAARs influences colonic 458 
contraction, we applied the GABAAR subunit-selective imidazopyridine zolpidem to 459 
isolated mouse colon segments and measured the changes in the force and 460 
frequency of spontaneous contractions. Within the CNS, zolpidem at a concentration 461 
of 100nM is a selective positive allosteric modulator (PAM) of α1-γ2-GABAARs, 462 
whereas a concentration of 1µM zolpidem has affinity not only for α1-γ2, but 463 
additionally α2/3-γ2-GABAARs (Langer et al., 1990; Crestani et al., 2000; Peden et 464 
al., 2008). Zolpidem at a bath concentration of 100nM significantly increased the 465 
force of spontaneous contractions (P = 0.0246, paired Student’s t test, N = 4 466 
animals) (Fig. 7C1, 2). However, zolpidem at this concentration had no significant 467 
effect on the frequency of spontaneous contractions (P = 0.4228, paired Student’s t 468 
test; N = 4 animals) (Fig. 7C1, 3).  469 
Expression of the α2, 3 subunits in the mouse colon and their role in the regulation of 470 
longitudinal smooth muscle spontaneous contractions 471 
Immunoreactivity for the α2 subunit was more restricted compared to other subunits 472 
investigated and was localised preferentially on MAP2-immunopositive neurons of 473 
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the myenteric plexus (Fig. 8A). In addition, within this region, α2 subunit 474 
immunoreactive clusters also decorated c-Kit immunopositive profiles, the putative 475 
ICC (Fig. 8A). There was a noticeable gradient in the comparative levels of α2 476 
subunit immunoreactivity in NOS-immunopositive neurons of the myenteric and 477 
submucosal plexuses with the latter exhibiting strikingly higher levels of signal, 478 
which, in a similar manner to other GABAAR subunits, was located cytoplasmically 479 
(Fig. 8B, C). Finally, somatostatin immunoreactive varicosities were closely apposed 480 
to α2 subunit immunoreactive clusters within the myenteric plexus (Fig. 8D) 481 
suggesting that GABA released from somatostatin-expressing neurons may signal 482 
via α2-GABAARs. Indeed, somatostatin is a neurochemical signature of GABAergic 483 
interneurons within the ENS (Furness, 2006). Immunoreactivity for the α3 subunit 484 
was restricted to the somatic and dendritic domains of somatostatin-immunopositive 485 
neurons (Fig. 8E) as well as neurons contacted by Chat-immunopositive varicosities 486 
(Fig. 8F) within the myenteric plexus. Furthermore α3 subunit immunoreactivity 487 
clusters were evident within the muscle layer and distinctly associated with NOS-488 
immunopositive varicosities and c-Kit Immunopositive ICCs (Fig. 8G).  489 
 490 
In order to investigate the potential functional roles of α2/3-GABAARs in colonic 491 
contractility we applied zolpidem 1 µM to isolated mouse colon and measured the 492 
changes in the force and frequency of spontaneous contractions. At this 493 
concentration, zolpidem is expected to enhance the function of α2/3-γ2 in addition to 494 
α1-γ2-GABAARs (Peden et al., 2008). Zolpidem at a bath concentration of 1 µM 495 
significantly decreased the force of spontaneous contractions (P = 0.0133, paired 496 
Student’s t test; N = 4 animals) (Fig. 8H1) and increased their frequency (P = 0.0237, 497 
paired Student’s t test; N= 4 animals) (Fig. 8H2). To dissect the potential contrasting 498 
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roles of α2- and α3-GABAARs on the force and frequency of spontaneous colonic 499 
contractions, we utilised the GABAAR ligand TP003 which in recombinant systems is 500 
a selective PAM of α3-γ2-GABAARs (Dias et al., 2005). A caveat is that TP003 may 501 
lack this α3 subunit selectively in native GABAAR expression systems (Peden et al., 502 
2008). TP003 at a bath concentration of 100 µM significantly decreased the force of 503 
spontaneous contractions (P = 0.024, paired Student’s t test; N = 4 animals) (Fig. 504 
8I1) but had no significant effect on their frequency (P = 0.294, paired Student’s t 505 
test; N = 4 animals) (Fig. 8I2). Collectively, the effects of zolpidem 1 µM and TP003 506 
suggest that the activation of α2-GABAARs influences the frequency of spontaneous 507 
colonic contractions whereas the activation of α3-GABAARs influences the force of 508 
spontaneous colonic contractions.  We were unable to fully reverse the effects of 509 
both zolpidem and TP003 by washout and thus not able to use atropine or L-NAME 510 
to evaluate the potential roles of muscarinic cholinergic receptors and nitric oxide 511 
pathways in mediating the effects of these drugs. 512 
 513 
Expression of the α4 subunit in the mouse colon and its role in the regulation of 514 
longitudinal smooth muscle spontaneous contractions 515 
In contrast to that of the γ2 subunit, α4 subunit immunoreactivity was restricted to the 516 
neurons and ICC of the myenteric plexus and was not detectable within the 517 
submucosal plexus (Fig. 9A). Clusters immunoreactive for the α4 subunit were 518 
located on somato-dendritic domains of NOS, Chat, 5HT and CRH immunopositive 519 
neurons (Fig. 9A, B). Thus, within the ENS of the mouse colon, GABAAR subunit 520 
expression varies not only according to cell-type and sub-cellular domain but also 521 
according to distinct regions of the ENS delineated by the myenteric and submucosal 522 
plexuses.  523 
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The lack of availability of a selective α4-GABAAR ligand precluded the unequivocal 524 
determination of the contribution of α4-GABAAR activation to colonic contractility. We 525 
therefore utilised the GABAAR agonist THIP which will be selective for those α4-526 
GABAARs which are co-assembled with δ subunits (Brown et al., 2002; Storustovu 527 
and Ebert, 2006) with the caveat that GABAARs not composed of γ or δ subunits (i.e. 528 
α-β pentamers) might also be engaged. THIP, at a bath concentration of 10 µM 529 
significantly increased the force of spontaneous contractions (from 0.11 ± 0.04 530 
grams to 0.19 ± 0.09 grams, N = 5 animals; P = 0.0299, paired Student’s t test) but 531 
did not significantly alter their frequency (from 0.052 ± 0.005 Hz to 0.051 ± 0.009 Hz, 532 
N = 5 animals; P = 0.5583, paired Student’s t test).  533 
 534 
We then evaluated the effects of THIP in the presence of atropine and L-NAME. 535 
Whilst THIP significantly increased the force of colonic contractions on its own (P < 536 
0.05, RMA), this effect was abolished in the presence of atropine (P > 0.05, RMA; N 537 
= 5 animals) (Fig. 9 C1, 2). In accordance with above, THIP had no significant effect 538 
on the frequency of spontaneous contractions either alone (P > 0.05, RMA) or in the 539 
presence of atropine (P > 0.05, RMA) (Fig. 9 C3).  540 
 541 
In contrast to atropine, the significant [F (2, 6) 13.6; P = 0.0059. RMA] THIP-induced 542 
increase in the force of colonic contractions (P < 0.05, RMA) persisted in the 543 
presence of L-NAME (P < 0.05, RMA; N = 3 animals) (Fig. 9 D1, 2). Once again, 544 
THIP had no significant effect on the frequency of spontaneous contractions either 545 
alone (P > 0.05, RMA) or in the presence of L-NAME (P > 0.05, RMA) (Fig. 9 D3). 546 
Thus, the muscarinic cholinergic system but not the nitric oxide system appears to 547 
be involved in mediating the effects of THIP on the force of colonic contractions.  548 
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Expression of the α5 subunit in the mouse colon and its role in the regulation of 549 
longitudinal smooth muscle spontaneous contractions 550 
In a similar pattern to α4 subunit immunoreactivity, signal for the α5 subunit was 551 
restricted to neurons and putative ICC of the myenteric plexus with no α5 subunit 552 
immunoreactivity detectable in the submucosal plexus (Fig. 10A). Within the 553 
myenteric plexus, immunoreactivity for the α5 subunit was located on the somato-554 
dendritic domains of NOS, CRH and 5HT immunopositive neurons as well as 555 
apposed to Chat immunoreactive varicosities (Fig. 10Ai, B).  556 
 557 
L-655,708, an inverse agonist selective for the benzodiazepine site at α5-γ2-558 
GABAARs (Quirk et al., 1996), was used to investigate the functional implications of 559 
α5-GABAARs activity on the force and frequency of spontaneous contractions of the 560 
mouse colon. L-655,708 at a bath concentration of 10 µM induced a profound 561 
reduction in the basal tone of the tissue (Fig. 10C1, double arrow) (from - 0.28 ± 0.16 562 
grams to -0.58 ± 0.18 grams, N = 8 animals; P < 0.0001, paired Student’s t test). 563 
Furthermore, L-655,708 10 µM significantly decreased the force of spontaneous 564 
contractions (from 0.13 ± 0.05 grams to 0.10 ± 0.02 grams, N= 8 animals; P = 565 
0.0316, paired Student’s t test). However, L-655,708 did not significantly alter the 566 
frequency of contractions (from 0.058 ± 0.010 Hz to 0.058 ± 0.011 Hz, N = 8 567 
animals; P = 0.8398, paired Student’s t test). Notably, out of all the GABAAR ligands 568 
tested L-655,708 produced the most robust reduction in the basal tone of the tissue 569 
with only alprazolam mimicking such an effect, although to a much lesser degree. 570 
This suggests a central role for α5-GABAARs in setting the muscle tone of the mouse 571 
colon.   572 
 573 
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In a separate experiment, we then evaluated the effects of L-655,708 in the 574 
presence of atropine and L-NAME. L-655,708 significantly [F (5, 15) 3.23; P = 0.03, 575 
RMA] reduced the basal tone of the colon, both on its own (P < 0.05, RMA) and in 576 
the presence of atropine (P < 0.05, RMA; N = 6 animals). The effect of L-655,708 in 577 
significantly [F (5, 15) 4.79; P = 0.0081, RMA] reducing the force of colonic contractions 578 
(P < 0.05, RMA) persisted in the presence of atropine (P < 0.05, RMA) (Fig. 10 C1, 579 
2). In accordance with above, L-655,708 had no significant effect on the frequency of 580 
spontaneous contractions either alone (P > 0.05, RMA) or in the presence of 581 
atropine (P > 0.05, RMA) (Fig. 10 C3). The data suggest that the muscarinic 582 
cholinergic system is not associated with the effect of L-655,708 on the basal tone or 583 
force of colonic contractions.   584 
 585 
Whilst L-655,708 significantly [F (5, 15) 5.8; P = 0.003, RMA] reduced the basal tone of 586 
the colon on its own (P < 0.05, RMA), this effect was abolished in the presence of L-587 
NAME (P > 0.05, RMA; N = 6 animals). In contrast to atropine, the significant L-588 
655,708-induced [F (5, 15) 4.9; P = 0.007, RMA] decrease in the force of colonic 589 
contractions (P < 0.05, RMA) was abolished in the presence of L-NAME (N = 6 590 
animals; P > 0.05, RMA) (Fig. 10 D1, 2). Once again, L-655,708 had no significant 591 
effect on the frequency of spontaneous contractions either alone (P > 0.05, RMA) or 592 
in the presence of L-NAME (P > 0.05, RMA; N = 6 animals) (Fig. 10 D3). Thus, the 593 
nitric oxide system is involved in mediating the effects of L-655,708 on both basal 594 
tone and the force of colonic contractions.  595 
 596 
The effect of GABAAR activation on the stressed induced alterations in colonic 597 
longitudinal smooth muscle spontaneous contractions  598 
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Psychosocial stress is a key contributor to the underlying pathology of a number of 599 
GI disorders (Konturek et al., 2011) such as inflammatory bowel disease (IBD) and 600 
irritable bowel syndrome (IBS) (Tache et al., 2004; Mawdsley and Rampton, 2005; 601 
Fichna and Storr, 2012). With a view to elucidating a potential role for GABAAR 602 
ligands in influencing stress-induced alterations in colonic contractions, we 603 
compared the effects of alprazolam in tissue from control animals and animals 604 
exposed to 1 hour of restraint stress. While alprazolam at a bath concentration of 10 605 
µM predictably (see Fig. 3) reduced the basal tone of tissue from control animals 606 
(Fig. 11 A1, double arrow), this effect was negligible in tissue from stress animals 607 
(Fig. 11 A2) (control, - 0.17 ± 0.07 grams versus stress, -0.06 ± 0.01 grams, N = 8 608 
animals; P = 0.0021, unpaired Student’s t test). The force of baseline spontaneous 609 
contractions were significantly larger in tissue from stress animals compared with 610 
control (control, 0.11 ± 0.01 versus stress, 0.19 ± 0.01, N =7, P < 0.001, RMA) with 611 
large rhythmic contractions superimposed on smaller contractions evident in tissue 612 
from stress animals (Fig. 11A2, arrows). Alprazolam significantly decreased [F (2.401, 613 
14.40) = 44.48, P < 0.0001, RMA] the force of spontaneous colonic contractions in 614 
both control (N = 7 animals; P < 0.001, RMA) and stress tissue (P < 0.001, RMA; N = 615 
7 animals). Although the same concentration of alprazolam induced a greater 616 
percentage reduction in the force of spontaneous colonic contractions in tissue from 617 
stress animals compared to control tissue (mean ± SD % reduction; control, 39.76 ± 618 
11.4 % versus stress, 53.26 ± 14.5 %), the effect did not reach statistical significance 619 
(P = 0.07, unpaired Student’s t test). However, it is notable that alprazolam reduced 620 
the force of spontaneous contractions in tissue from stress animals to the levels 621 
exhibited at baseline for control tissue (Fig. 11 B1). Stress did not significantly alter 622 
the frequency of spontaneous contractions (P > 0.05, RMA; N =7). While alprazolam 623 
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predictably significantly increased the frequency of spontaneous colonic contractions 624 
in tissue from control mice (P < 0.001, RMA), this effect was not evident in tissue 625 
from stress animals (P > 0.05, RMA). Collectively, these data suggest that drugs 626 
targeting γ2-GABAAR have the potential to reverse changes in the force of colonic 627 
contractions arising from exposure to stressors. 628 
  629 
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Discussion 630 
 631 
The study shows that immunoreactivity for the α1 and γ2 subunits was the most 632 
widespread compared to the other subunits investigated, being located on 633 
chemically diverse neurons of both myenteric and submucosal plexuses. This 634 
preponderance of α1-γ2 subunit immunoreactivity within the ENS mirrors GABAAR 635 
expression patterns within the CNS where α1-γ2-GABAARs are thought to be the 636 
major subtypes (Wisden et al., 1992). While immunoreactivity for the α2 and 3 637 
subunits was also evident in myenteric and submucosal plexuses, their signals were 638 
restricted to smaller sub-sets of neurochemically defined enteric neurons. In stark 639 
contrast, immunoreactivity for the α4-5 subunits was only detectable in myenteric 640 
plexus neurons. GABAAR subunit immunoreactivity was also located on non-641 
neuronal cells which are likely to be the ICC that act as pace-makers of the GIT and 642 
are involved in the creation of slow wave potentials which leads to the contraction of 643 
smooth muscle (Garcia-Lopez et al., 2009). The application of GABAAR subunit 644 
preferring ligands induced contrasting effects on the force and frequency of 645 
spontaneous contraction of longitudinal smooth muscles of the colon in vitro. Finally, 646 
α-γ2-GABAAR activation reversed the stress-induced increase in the force of 647 
spontaneous contractions. The study reveals the rich molecular and functional 648 
diversity of the GABAAR system within the ENS of the mouse colon and provides a 649 
platform for the design of GABAAR-based formulations targeted specifically for GI 650 
disorders 651 
 652 
 653 
 654 
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Implications of GABAAR subunit expression patterns for colon contractility 655 
The ENS is capable of providing complete neural control of GI functions independent 656 
of input from the CNS (Furness, 2006). Within the mammalian ENS, over thirty 657 
functionally distinct types of neurons have been discovered which communicate 658 
using more than 25 different neurotransmitters (McConalogue and Furness, 1994; 659 
Furness, 2000), including GABA (Jessen et al., 1986). At the organ level, GABA, 660 
released predominantly from interneurons and endocrine cells (Krantis, 2000; 661 
Furness, 2006), influences various GI functions including motility (Cherubini and 662 
North, 1984), secretion (Luzzi et al., 1987) and mucosal function (Hardcastle et al., 663 
1991; MacNaughton et al., 1996). At the single cell level, applied GABA depolarises 664 
myenteric neurons and thus exerts excitatory postsynaptic effects in the ENS 665 
(Cherubini and North, 1984) via GABAARs (Cherubini and North, 1985). However, 666 
the precise effects of various GABAAR subtypes on the excitability of the functionally 667 
and neurochemically diverse ENS neurons remain to be revealed, necessitating a 668 
detailed description of their expression patterns in the first instance.  669 
 670 
A striking feature of the GABAAR subunit immunoreactivity patterns revealed by this 671 
study was the plexus-dependent location of the signal. GABAAR subunit 672 
immunoreactivity in myenteric plexus neurons was always located on somato-673 
dendritic cell surfaces, irrespective of the neurochemical content of the cell. This 674 
clustering on postsynaptic domains is the conventional GABAAR subunit expression 675 
pattern of the CNS (Fritschy and Mohler, 1995; Nusser et al., 1996; Somogyi et al., 676 
1996) and serves to regulate the neuron which is postsynaptic to the GABA release 677 
site (Farrant and Nusser, 2005). In contrast, GABAAR subunit immunoreactivity in 678 
submucosal neurons was invariably located cytoplasmically and on axonal 679 
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varicosities. This suggests a presynaptic locus of expression for GABAARs in 680 
submucosal neurons which is likely to result in an auto-regulatory function that could 681 
influence the further release of co-expressed neurotransmitters (Kullmann et al., 682 
2005). It is difficult to speculate what eventual net effect GABAAR activation will have 683 
on, for example, myenteric plexus output such as colonic contractility given the fact 684 
that non-overlapping populations of NOS-, somatostatin- or encephalin-685 
immunopositive GABAergic interneurons innervate both excitatory as well as 686 
inhibitory neurons (Krantis, 2000). An added layer of complexity was the association 687 
of GABAAR subunit immunoreactivity with non-neuronal cells, which, based on their 688 
immunoreactivity, are likely to be the ICC. ICC are thought to provide pacemaker 689 
activity in terms of intestinal contractions (Garcia-Lopez et al., 2009) suggesting a 690 
clear role for GABAARs in intestinal motility. Collectively, this cell-type-specific 691 
targeting of GABAARs to either pre- or postsynaptic compartments of submucosal 692 
and myenteric plexuses respectively is likely to result in contrasting effects on the 693 
excitability of the neurons, the ensuing overall output of the plexuses as a whole, and 694 
thus GI function, following the application of GABA or the ingestion of GABAAR 695 
ligands.  696 
 697 
To gain a perspective on the potential contributions of various GABAAR subtypes to 698 
GI function, we concentrated on the myenteric plexus in light of its readily 699 
measurable physiological output, namely colonic spontaneous contractility. Despite 700 
the widespread expression of various GABAAR subunits throughout the ENS, it is 701 
notable that the GABAAR subunit-preferring ligands had such distinctly opposing 702 
effects on longitudinal smooth muscle contractility. Indeed, the pharmacological 703 
activation of α1-γ2-GABAARs and α4-GABAARs increased the force of spontaneous 704 
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contractions, α2-γ2-GABAARs increased their frequency, α3-γ2-GABAARs decreased 705 
their force and an inverse agonist at α5-γ2-GABAARs decreased their force. This 706 
suggests that the engagement of various GABAAR subtypes within the cellular 707 
networks of the ENS cooperate to modulate the distinct physiological processes 708 
which underlie coordinated contractility. It would be beneficial to understand which 709 
particular GABAAR-cellular pathway modulates distinct facets of the contractile 710 
process such as amplitude or frequency. While the current study suggests the 711 
overlap of multiple GABAAR subtypes on neurochemically diverse cell-types, such as 712 
those expressing NOS and Chat, these combinatorial pharmacological analyses 713 
allow us to draw cautious conclusions on the neurochemical and cellular pathways 714 
mediating the GABAAR-subtype dependent effects on the force and frequency of 715 
longitudinal muscle colonic contractions. For example, alprazolam, which is likely to 716 
preferentially engage α2-3-γ2-GABAARs, appeared to induce a decrease in the force 717 
of contractions via NO pathways. In accordance, Furthermore, α2/3-GABAAR 718 
immunoreactivity was associated with somatostatin-immunopositive neurons, the 719 
activation of which via GABAARs is linked to the release of nitric oxide and 720 
vasoactive intestinal peptide (VIP) from inhibitory motor neurons (Krantis, 2000) and 721 
a consequent decrease in intestinal motility, an effect manifested by the 722 
pharmacological activation of α2/3-γ2-GABAARs. The obvious caveat is that the 723 
pharmacology of the GABAAR subunit-preferring ligands has been demonstrated 724 
predominantly in either recombinant systems or CNS preparations. Thus, the future 725 
characterisation of these ligands in GI tissue from GABAAR subunit-specific mutant 726 
mouse models will be instrumental in confirming their pharmacological profiles in 727 
colon tissue. 728 
 729 
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GABAARs and stress-induced GI disorders 730 
Dysregulation of the ENS contributes to the pathophysiology of a number of GI 731 
disorders including IBS and IBD (Margolis and Gershon, 2009; Ohman and Simren, 732 
2010). A key component of such disorders as well as other GI disorders is 733 
psychosocial stress (Mawdsley and Rampton, 2005; Santos et al., 2008). CRH, 734 
released primarily from the hypothalamus, is the key mediator of the body’s 735 
response to stress (Bale and Vale, 2004). However, there are a number of extra-736 
hypothalamic sources of CRH throughout the body, including the ENS (Liu et al., 737 
2006), presumably functioning to mediate the stress response at a local level 738 
(Stengel and Tache, 2010). Importantly, changes in GI CRH and CRH receptor 739 
expression within certain disorders of the GIT have been reported (Tache et al., 740 
2004; Tache and Perdue, 2004; Yuan et al., 2012). The excitability of CRH-741 
containing ENS neurons is likely to determine CRH release within the GIT and is 742 
thus integral to GI homeostasis following exposure to stressors. It is notable that 743 
robust GABAAR subunit expression was evident on enteric CRH neurons. Since the 744 
GABAARs provide such a central role in regulating neuronal activity, and thus the 745 
release of neuronal contents, the modulation of GABAAR activity specifically on 746 
enteric CRH-expressing neurons might provide a highly specific strategy for targeting 747 
stress-induced GI disorders. Based on the immunoreactivity patterns within this 748 
study, drugs targeting α1/4/5-GABAAR are likely to influence the activity of at least 749 
the CRH-expressing neurons of the ENS. Thus, determining the precise effects of 750 
various GABAAR ligands on the excitability of defined sets of ENS neurons is 751 
essential for the further judicious design and use of such agents in GI disorders.   752 
 753 
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Importantly, stressors have been shown to cause a decrease in gastric emptying, an 754 
increase in distal colonic motility and acceleration of intestinal transit (Mayer, 2000). 755 
It is thus promising that alprazolam in this study was able to reverse the stress-756 
induced increase in the force of colonic contractions. However, it is currently unclear 757 
what the contribution of such stress-induced increase in contractile responses is to 758 
stress-related GI pathology, if any. Surprisingly, out of the number of therapeutic 759 
agents considered for conditions such as IBS or IBD, GABAAR ligands are largely 760 
overlooked (Hammerle and Surawicz, 2008; Saad and Chey, 2008), although recent 761 
evidence is promising (Salari and Abdollahi, 2011). The rich field of GABAAR 762 
pharmacology (Rudolph and Mohler, 2006; Rudolph and Knoflach, 2011) is littered 763 
with agents that showed promising pharmacological profiles but translated poorly to 764 
the clinic due to either unacceptable central side effects or poor CNS penetration. 765 
The current study provides the scientific rationale for the re-evaluation of such 766 
agents with a view to reformulating them specifically for delivery to the GIT. In 767 
conclusion, the study provides a detailed description of the location of diverse 768 
GABAAR subunits expressed within the complex network of neurons composing the 769 
ENS of the mouse colon. The fledgling functional analyses provides a firm mandate 770 
for further exploring the individual roles of specific GABAAR subtypes in GI functional 771 
and associated disorders.  772 
 773 
 774 
 775 
 776 
 777 
  778 
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Figure Legends 1023 
Figure 1 1024 
GABAAR subunit mRNA expression in the mouse colon  1025 
Representative gel electrophoresis images of mRNA transcripts for various GABAAR 1026 
subunits using RT-PCR and homogenates from whole mouse brain and colon. 1027 
Corresponding amplicons of the same size to those obtained from brain samples 1028 
were consistently detected for the GABAAR α1-5, β1-3, γ1-3 and δ subunits but not 1029 
the α6 and ε subunits in colon samples (N = 3 animals). A negative control, no RT 1030 
reaction was performed with every experiment.  1031 
 1032 
Figure 2 1033 
Immunolocalisation of putative inhibitory synaptic marker proteins in the ENS of the 1034 
mouse colon 1035 
(Ai) immunoreactivity for the somato-dendritic marker protein microtubule associated 1036 
protein 2 (MAP2) (blue) demonstrates the location of neurons within ganglia of the 1037 
myenteric plexus. Immunoreactivity for the GABAergic presynaptic marker protein 1038 
vesicular GABA transporter (VGAT) (red) shows the widespread GABAergic 1039 
innervation of neurons throughout the ENS. (Aii) shows immunoreactivity for the 1040 
interstitial cells of Cajal (ICC) marker protein c-Kit (green) within the same field of 1041 
view as (Ai). (Aiii) is an overlay of (Ai and Aii) and demonstrates the association of 1042 
VGAT immunoreactivity with neuronal and non-neuronal cells of the ENS within the 1043 
mouse colon. (Bi) shows immunoreactivity for the voltage-gated potassium channel 1044 
2.1 (Kv2.1) (blue) which delineates somato-dendritic plasma membranes as well as 1045 
immunoreactivity for neuroligin2 (NL2), a protein which in the CNS is located 1046 
exclusively in inhibitory synapses (green). (Bii) shows immunoreactivity for VGAT 1047 
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within the same field of view as (Bi). (Biii) is an overlay of (Bi and Bii) demonstrating 1048 
the close association between putative presynaptic VGAT and postsynaptic NL2 1049 
immunoreactive clusters (arrowheads) and thus the likely locations of GABAergic 1050 
synapses. (Ci) shows nitric oxide synthase (NOS) immunoreactive axon terminals 1051 
(blue) which are also immunopositive for VGAT (red). (Cii) VGAT immunoreactive 1052 
puncta are apposed to cellular profiles immunoreactive for c-Kit which are likely to be 1053 
ICC. (Ciii) is an overlay of (Ci and Cii) showing the close association between 1054 
GABAergic axon terminals and the profiles of ICC. The insert is a magnified view of 1055 
the boxed area. Scale bars: (A) 30 µm; (B) 5 µm; (C) 20 µm; insert, 2 µm.   1056 
 1057 
Figure 3 1058 
Immunolocalisation of the GABAAR γ2 subunit in the ENS of the mouse colon and 1059 
the pharmacological effect of activating γ2-GABAARs on spontaneous colonic 1060 
longitudinal smooth muscle contractions 1061 
(A1) shows immunoreactivity for the γ2 subunit is widely distributed on neurons of 1062 
the myenteric plexus visualised by NOS immunoreactivity (insert). Immunoreactivity 1063 
for the γ2 subunit was located on somato-dendritic surfaces of (A2) serotonergic-1064 
immunopositive (5HT)-, (A3) corticotrophin releasing hormone (CRH)-1065 
immunopositive, (A4) somatostatin-immunopositive (SOM)- and (A5) choline acetyl 1066 
transferase (Chat)-immunopositive myenteric plexus neurons. (B) in contrast to the 1067 
surface location of γ2 subunit immunoreactivity on myenteric plexus neurons (A), the 1068 
signal in submucosal plexus neurons (asterisks) identified by NOS immunoreactivity, 1069 
was located predominantly within the cytoplasm as well as in c-Kit immunopositive  1070 
profiles (arrowheads). The inserts are magnified views of the cell identified by the 1071 
arrow. (C) within the muscle layer, γ2 subunit immunoreactivity was closely 1072 
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associated with (Ci) NOS-immunopositive axon terminals and (Cii) c-Kit 1073 
immunopositive profiles (asterisks). (D1) representative trace demonstrating the 1074 
effect of the benzodiazepine alprazolam 10 µM on spontaneous contractions in a 1075 
piece of isolated mouse colon in the absence and presence of the muscarinic 1076 
cholinergic receptor antagonist atropine 1 µM. Quantification of the effects of 1077 
alprazolam 10 µM, before and after the co-application of atropine on (D2) the force 1078 
and (D3) the frequency of spontaneous colonic contractions. (E1) representative 1079 
trace demonstrating the effect of alprazolam 10 µM on spontaneous contractions in a 1080 
piece of isolated mouse colon in the absence and presence of the nitric oxide 1081 
synthase inhibitor L-NAME 10 µM. Quantification of the effects of alprazolam 10 µM, 1082 
before and after the co-application of L-NAME on (E2) the force and (E3) the 1083 
frequency of spontaneous colonic contractions. Bars represent means and the lines 1084 
represent the SD. N = 7 animals, * P < 0.05, repeated measures ANOVA with 1085 
posthoc Tukey’s test.  Scale bars: (A1) 20 µm; (A2-5) 10 µm; (B, C) 20 µm; (D1, E1) 1086 
vertical 0.25 grams, horizontal 2 minutes. 1087 
 1088 
Figure 4 1089 
Effect of alprazolam on electrically evoked contractile responses of colon longitudinal 1090 
smooth muscles 1091 
(A) shows representative records of the contractile responses of a colon segment 1092 
following electrical field transmural stimulation (EFS) either alone or in the presence 1093 
of tetrodotoxin (TTX), which blocks neural activity, or alprazolam. Note that both TTX 1094 
and alprazolam attenuate the evoked response largely to the same degree. (B) 1095 
quantification of the effects of TTX and alprazolam on the evoked contractile 1096 
responses. Bars represent the mean percentage of the maximal response and the 1097 
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lines represent the SD. N = 4 animals, * P < 0.05, paired Student’s t test. Scale bars 1098 
(A1) vertical 0.1 grams, horizontal 30 seconds. 1099 
 1100 
Figure 5 1101 
Confirmation of the specificity of the GABAAR α subunit immunoreactivity using 1102 
tissue from the brains of wild type (WT) (α+/+) and GABAAR α1-5 subunit-specific 1103 
gene-deleted mice (α-/-) 1104 
(A1, B1, D1, E1) shows characteristic immunoreactivity patterns for the α1-2, 4-5 1105 
subunits in the hippocampus and neocortex of WT mouse brain respectively. (C1) 1106 
shows the characteristic enrichment of α3 subunit immunoreactivity within the 1107 
reticular nucleus of the thalamus (nRT). (A2, B2, C2, D2, and E2) no specific signal 1108 
was detectable in brain tissue from the appropriate α-/- mice. Scale bars 200 µm. 1109 
 1110 
Figure 6 1111 
Confirmation of the specificity of the GABAAR α subunit immunoreactivity using 1112 
tissue from the colons of wild type (WT) (α+/+) and GABAAR α1-5 subunit-specific 1113 
gene-deleted mice (α-/-) 1114 
(A1-E1) are images of whole-mount preparations of the ENS of WT mouse colon 1115 
demonstrating myenteric plexus neurons identified by (A1i-E1i) NOS 1116 
immunoreactivity. (A1ii-E1ii) in the corresponding fields of view, α1-5 subunit 1117 
immunoreactivity respectively is strongly associated with myenteric plexus neurons. 1118 
(A2i-E2i) are images of whole-mount preparations of the ENS of α1-5-/- colon 1119 
respectively demonstrating myenteric plexus neurons identified by NOS 1120 
immunoreactivity. (A2ii-E2iii) in the corresponding fields of view, no specific α1-5 1121 
subunit signal respectively was detectable. Scale bars: (A, B) 40 µm. 1122 
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Figure 7 1123 
Immunolocalisation of the GABAAR α1 subunit in the ENS of the mouse colon and 1124 
the pharmacological effect of activating α1-GABAARs on spontaneous colonic 1125 
longitudinal smooth muscle contractions 1126 
(A1) shows clustered α1 subunit immunoreactivity (red) widely distributed on the 1127 
somato-dendritic surfaces of MAP2-immunopositive myenteric plexus neurons 1128 
(blue). (A2i) shows that α1 subunit immunoreactivity (red) on plasma-membrane 1129 
surfaces, identified by Kv2.1 immunoreactivity (blue) is closely apposed to (A2ii, iii) 1130 
VGAT immunoreactive puncta (green) and thus likely GABAergic synaptic junctions. 1131 
Immunoreactivity for the α1 subunit was located on somato-dendritic surfaces of (A3) 1132 
NOS-immunopositive, (A4) Chat-immunopositive, (A5) 5HT-immunopositive and (A6)  1133 
CRH-immunopositive myenteric plexus neurons as well as (A7) Chat-1134 
immunopositive axon terminals in the muscle layer.  (B) shows that α1 subunit 1135 
immunoreactivity within neurons of the submucosal plexus was located on 1136 
cytoplasmic and axonal compartments.  (Bii) is a magnified view of the boxed area in 1137 
(Bi). (C1) representative trace demonstrating the effects of the application of 1138 
zolpidem at a concentration of 100nM (α1-GABAAR selective agonist) on the 1139 
spontaneous contractions in a piece of isolated colon. Quantification of the effects of 1140 
zolpidem 100nM on (C2) the force and (C3) the frequency of spontaneous colonic 1141 
contractions. Boxes represent means, the lines represent the SD and the small 1142 
squares represent the individual data points. N= 4 animals. * P < 0.05 paired 1143 
Student’s t test. Scale bars: (A) 10 µm; (A7 insert) 2 µm; (B) 10 µm; (C1) vertical 0.5 1144 
grams, horizontal 5 minutes. 1145 
 1146 
 1147 
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Figure 8 1148 
Immunolocalisation of the GABAAR α2 and 3 subunits in the ENS of the mouse colon 1149 
and the pharmacological effect of activating α2/3-GABAARs on spontaneous colonic 1150 
longitudinal smooth muscle contractions 1151 
(A) shows the association of α2 subunit immunoreactivity with neuronal and non-1152 
neuronal cellular profiles in ENS of the mouse colon. (Ai) is an overlay of 1153 
immunoreactivity patterns for MAP2 (blue) a marker of neurons, c-Kit (green) a 1154 
marker of ICC and the α2 subunit (red). (Aii) is a magnified view of the boxed area in 1155 
(Ai) showing the significant association between α2 subunit immunoreactive clusters 1156 
with MAP2-immunopositive somata and dendrites. (Aiii) in the corresponding field of 1157 
view numerous α2 subunit immunoreactive clusters are located on c-Kit 1158 
immunopositive profiles (arrowheads). (B) shows α2 subunit immunoreactivity on the 1159 
somato-dendritic surfaces of NOS-immunopositive myenteric plexus neurons. (C) 1160 
shows the comparative cytoplasmic immunoreactivity pattern for the α2 subunit in 1161 
NOS-immunopositive submucosal plexus neurons. (D) shows α2 subunit 1162 
immunoreactivity clusters closely apposed to SOM-immunopositive puncta within the 1163 
myenteric plexus. The insert is a magnified view of the area highlighted by the 1164 
asterisk. (E) shows α3 subunit immunoreactive clusters on the cell body of a SOM-1165 
immunopositive myenteric plexus neuron. (F) shows α3 subunit immunoreactive 1166 
clusters closely associated with Chat-immunopositive varicosities. (Gi) shows α3 1167 
subunit immunoreactive clusters decorating NOS-immunopositive axon terminals in 1168 
the muscle layer. (Gii) in the corresponding field of view, α3 subunit immunoreactive 1169 
clusters are located in close proximity to c-Kit-immunopositive profiles.  The inserts 1170 
on the left of (Gi and Gii) are magnified views of the boxed area. The insert on the 1171 
right of (Gii) is a magnified merged image of all three channels demonstrating the 1172 
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juxtaposition of α3 subunit immunoreactive clusters between NOS-immunopositive 1173 
axon terminals and c-Kit immunopositive profiles which are likely to be ICC. (H) 1174 
quantification of the effects of zolpidem 1 µM on (H1) the force and (H2) the 1175 
frequency of spontaneous colonic contractions (N = 4 animals). (I) quantification of 1176 
the effects of TP003 100 µM on (I1) the force and (I2) the frequency of spontaneous 1177 
colonic contractions (N = 4 animals). Boxes represent means, the lines represent the 1178 
SD and the small squares represent the individual data points. * P < 0.05 paired 1179 
Student’s t test. Scale bars: (Ai) 20 µm; (Aii, iii) 10 µm; (B-D) 10 µm; (E, F) 5 µm; (G) 1180 
50 µm.  1181 
 1182 
Figure 9 1183 
Immunolocalisation of the GABAAR α4 subunit in the ENS of the mouse colon and 1184 
the pharmacological effect of activating α4-GABAARs on spontaneous colonic 1185 
longitudinal smooth muscle contractions 1186 
(Ai) shows the association of α4 subunit immunoreactive clusters (red) with NOS-1187 
immunopositive neurons (blue) of the myenteric plexus. (Aii) shows the association 1188 
of α4 subunit immunoreactive clusters (red) with c-Kit immunopositive profiles 1189 
(green) in the same field of view. (Aiii) is a magnified view of the boxed areas in (Ai, 1190 
ii) demonstrating that α4 subunit immunoreactive clusters decorate the surfaces of 1191 
NOS-immunopositive somata and dendrites as well as c-Kit immunopositive 1192 
processes. (B1) shows that α4 subunit immunoreactive clusters are located in the 1193 
close vicinity of Chat-immunopositive varicosities in the myenteric plexus. 1194 
Immunoreactivity for the α4 subunit was also detectable on the somato-dendritic 1195 
domains of (B2) 5HT- and (B3) CRH-immunopositive myenteric plexus neurons. (C1) 1196 
representative trace demonstrating the effect of THIP 10 µM on spontaneous 1197 
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contractions in a piece of isolated mouse colon in the absence and presence of the 1198 
muscarinic cholinergic receptor antagonist atropine 1 µM. Quantification of the 1199 
effects of THIP, before and after the co-application of atropine on (C2) the force and 1200 
(C3) the frequency of spontaneous colonic contractions. (D1) representative trace 1201 
demonstrating the effect of THIP 10 µM on spontaneous contractions in a piece of 1202 
isolated mouse colon in the absence and presence of the nitric oxide synthase 1203 
inhibitor L-NAME 10 µM. Quantification of the effects of THIP, before and after the 1204 
co-application of L-NAME on (D2) the force and (D3) the frequency of spontaneous 1205 
colonic contractions. Bars represent means and the lines represent the SD. N = 5 1206 
animals, * P < 0.05, repeated measures ANOVA with post-hoc Tukey’s test. Scale 1207 
bars: Scale bars: (Ai, ii) 50 µm; (Aiii3) 10 µm; (B) 10 µm; (C1, D1) vertical 0.25 1208 
grams, horizontal 2 minutes.  1209 
 1210 
Figure 10  1211 
Immunolocalisation of the GABAAR α5 subunit in the ENS of the mouse colon and 1212 
the pharmacological effect of activating α5-GABAARs on spontaneous colonic 1213 
longitudinal smooth muscle contractions 1214 
(Ai) shows the association of α5 subunit immunoreactive clusters (red) with NOS-1215 
immunopositive neurons (blue) of the myenteric plexus. Note the significant number 1216 
of α5 subunit immunoreactive clusters located towards the centre of the field of view 1217 
which are not associated with neuronal profiles. (Aii) shows the strong association of 1218 
α5 subunit immunoreactive clusters (red) with c-Kit immunopositive profiles in the 1219 
same field of view. (Aiii) is an overlay of (Ai and ii). (B1) shows that α5 subunit 1220 
immunoreactive clusters are located in the close vicinity of Chat-immunopositive 1221 
varicosities in the myenteric plexus. Immunoreactivity for the α5 subunit was also 1222 
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detectable on the somato-dendritic domains of (B2) CRH- and (B3) 5HT-1223 
immunopositive myenteric plexus neurons. (C1) representative trace demonstrating 1224 
the effect of L-655,708 10 µM on spontaneous contractions in a piece of isolated 1225 
mouse colon in the absence and presence of the muscarinic cholinergic receptor 1226 
antagonist atropine 1 µM. Quantification of the effects of L-655,708, before and after 1227 
the co-application of atropine on (C2) the force and (C3) the frequency of 1228 
spontaneous colonic contractions. (D1) representative trace demonstrating the effect 1229 
of L-655,708 on spontaneous contractions in a piece of isolated mouse colon in the 1230 
absence and presence of the nitric oxide synthase inhibitor L-NAME 10 µM. 1231 
Quantification of the effects of L-655,708, before and after the co-application of L-1232 
NAME on (D2) the force and (D3) the frequency of spontaneous colonic 1233 
contractions. Bars represent means and the lines represent the SD. N = 5 animals, * 1234 
P < 0.05, repeated measures ANOVA with post-hoc Tukey’s test. Scale bars (A) 20 1235 
µm; (B) 10 µm; (C1, D1) vertical 0.25 grams, horizontal 2 minutes  1236 
  1237 
Figure 11 1238 
The effects of GABAAR activation on the stress induced alterations in the force and 1239 
frequency of colonic spontaneous contractions 1240 
(A) representative traces of the effects of alprazolam 10 µM on the contractile 1241 
responses of colon tissue obtained from (A1) control and (A2) stress animals. Note 1242 
in (A2) the stress-induced large amplitude rhythmic baseline contractions (arrows) 1243 
and the absence of the alprazolam-induced reduction in basal tone of the tissue 1244 
which is evident in the trace from control tissue (double arrow in A1). (B) 1245 
quantification of the comparative effects of   alprazolam 10 µM on the (B1) force and 1246 
(B2) frequency of spontaneous contractions in tissue from control and stress 1247 
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animals. Bars represent means and the lines represent the SD. N = 7 animals. P < 1248 
0.05, repeated measures ANOVA with post-hoc Tukey’s post-hoc test. Scale bars 1249 
(A) vertical 0.3 grams, horizontal 2.5 minutes 1250 
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Table 1 1273 
Table of RT-PCR primer sequences 1274 
Gene 
 
Primer sequence 
RT-PCR 
Product 
length (bp) 
Reference 
 
 
GABAAR 
α1 
 
CCA AGT CTC CTT CTG GCT CAA CA 
GGG AGG GAA TTT CTG GCA CTG AT 
 
 
111 
 
(Tan S et al., 2011). 
GABAAR 
α2 
TTA CAG TCC AAG CCG AAT GTC CC 
ACT TCT GAG GTT GTG TAA GCG TAG C 
 
 
103 
 
(Tan S et al., 2011). 
GABAAR 
α3 
CAA GAA CCT GGG GAC TTT GTG AA 
AGC CGA TCC AAG ATT CTA GTG AA 
 
 
119 
 
(Tan S et al., 2011). 
GABAAR 
α4 
GAG ACT GGT GGA TTT TCC TAT GG 
GGT CCA GGT GTA GAT CAT CTC ACT 
 
 
94 
 
(Tan S et al., 2011). 
GABAAR 
α5 
CCC TCC TTG TCT TCT GTA TTT CC 
TGA TGT TGT CAT TGG TCT CGT CT 
 
 
99 
 
(Tan S et al., 2011). 
GABAAR 
α6 
TAC AAA GGA AGA TGG GCT ATT 
ACG ATG GGC AAA GTC AGA GAG 
 
 
439 
 
(Glassmeier G et al., 
1998). 
GABAAR 
β1 
GGG GCT TCT CTC TTT TCC CGT GA 
GGT GTC TGG TAC CCA GAG TTG GT 
 
 
334 
 
(Gustincich S et al., 
1999). 
GABAAR 
β2 
CAA CTC TGG GTG CCT GAC ACC TA 
TCC TAA TGC AAC CCG TGC AGC AG 
 
 
495 
 
(Gustincich S et al., 
1999). 
GABAAR 
β3 
GGT TTG CTG CGC TCA GAG CGT AA 
TAC AGC ACT GTC CCA TCA GGG T 
 
 
390 
 
(Gustincich S et al., 
1999). 
GABAAR 
γ1 
CAG TTT GCA TTT GTA GGG TTA CG 
AGA CAC CCA GGA AAG AAC CAC TG 
 
 
165 
 
 
(Gustincich S et al., 
1999). 
GABAAR 
γ2 
GGT GGA GTA TGG CAC CCT GCA TT 
AGG CGG TAG GGA AGA AGA TCC GA 
 
 
322 
 
(Gustincich S et al., 
1999). 
GABAAR 
γ3 
TGC TCG GTC CAG GAG GGT AGA 
CTG ATC AGC TGC CTC AAC TGA ATT TTT 
 
 
592 
 
(Gustincich S et al., 
1999). 
GABAAR δ 
GAC TAC GTG GGC TCC AAC CTG GA 
ACT GTG GAG GTG ATG CGG ATG CT 
 
 
398 
 
(Gustincich S et al., 
1999). 
GABAAR ε 
CAA TGC GAA GAA CAC TTG GAA GC 
CTG GCA GCA GCA GCT TCT ATC TT 
 
 
225 
 
(Gustincich S et al., 
1999). 
β-actin 
AGG CCA ACC GTG AAA AGA TG 
ACC AGA GGC ATA CAG GGA CAA 
 
 
101 
 
(Gustincich S et al., 
1999). 
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Table 2  1277 
Details of primary antibodies used in the study 1278 
Antibody Host Dilution Source Specificity/Reference 
ChAT Goat 1:100 Millipore (AB144P) 
(Heinze et al., 2007). (Härtig et 
al., 2007). 
c-Kit Rat 1:250 eBioscience    (14-1172) 
(Sato et al., 1996). (Torihashi et 
al., 1995). 
CRF 
Guinea- 
pig 
1:1000 Peninsula Labs (T-5007) 
(Stanic et al., 2010). (Armstrong 
et al., 2009). 
  
GABAAR α1 Rabbit 1:5000 
Synaptic systems (224203) 
 
(Wisłowska-Stanek et al., 2013). 
No signal in knockout mouse, 
this study.   
GABAAR α2 Rabbit 1:1000 
Werner Sieghart, antigen 
sequence α2L amino acids 
322-357. R # 28/16 Bleed # 
01/10/2002 
(Pirker et al., 2000). No signal in 
knockout mouse, this study.  
GABAAR α3 
Guinea- 
pig 
1:3000 
Jean-Marc Fritschy, Antigen 
sequence α3N amino acids 1–
15. 
(Fritschy and Mohler, 1995). No 
signal in knockout mouse, this 
study.  
GABAAR α4 Rabbit 1:500 
Werner Sieghart, antigen 
sequence α4 amino acids 379-
421. R # 25/1 Bleed # 
19/03/2001 
(Pirker et al., 2000). No signal in 
knockout mouse, this study. 
GABAAR α5 Rabbit 1:1000 
Werner Sieghart, antigen 
sequence α5 amino acids 337-
388. R # 34/30 Bleed # 
17/12/2007 
(Pirker et al., 2000). No signal in 
knockout mouse, this study. 
GABAAR γ2 Rabbit 1:3000 
Synaptic system (224003) 
 
(Fish et al., 2013). No signal in 
knockout mice, This study.  
Kv2.1 Mouse 1:1000 
Neuromab 
(75-014) 
Western blot; band at 105-125 
kDa. No signal in knockout 
mice. (Hermanstyne et al., 
2010).  
Map-2 Chicken 1:500 Avēs Labs (MAP0607) 
Expression patterns as shown in 
previous studies 
Neuroligin2 Rabbit 1:1000 Synaptic Systems (129203) 
(Chih et al., 2005). (De Jaco et 
al., 2006).  
NOS Sheep 1:1000 Millipore (AB1529) 
(Liu et al., 2008). (Cauli et al., 
2004).  
Serotonin 
transporter 
Guinea- 
pig 
1:250 Chemicon (AB1772) 
(Häring et al., 2007). (Collin et 
al., 2000). 
Somatostatin Rat 1:500 Millipore (MAB354) 
(Tanaka et al., 2011). (Dimitrov 
and Usdin, 2010). 
VGAT 
Guinea- 
pig 
1:1000 Synaptic Systems (131004) 
(Schock et al., 2012). (Geis et 
al., 2010).  
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